Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.
Yang X, Ma X, Zhao T, Croucher DR, Nguyen EV, Clark KC, Hu C, Latham SL, Bayly-Jones C, Nguyen BV, Budnar S, Shin SY, Nguyen LK, Cotton TR, Chüeh AC, Lim Kam Sian TCC, Stratton MM, Ellisdon AM, Daly RJ.
Yang X, et al. Among authors: clark kc.
Nat Commun. 2025 Feb 22;16(1):1871. doi: 10.1038/s41467-025-57046-8.
Nat Commun. 2025.
PMID: 39984440
Free PMC article.